SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of Chelsea Therapeutics International, Ltd.
10 Maggio 2014 - 3:15AM
Business Wire
Law office of Brodsky & Smith, LLC announces that it is
investigating potential claims against the Board of Directors of
Chelsea Therapeutics International, Ltd. (“Chelsea” or the
“Company”) (Nasdaq: CHTP) relating to the proposed acquisition by
H. Lundbeck A/S (“Lundbeck”).
Click here to learn more about the investigation
http://brodsky-smith.com/756-chtp-chelsea-therapeutics-international-ltd.html,
or call: 877-534-2590. There is no cost or obligation to you.
Under the terms of the transaction, Chelsea shareholders will
receive only $6.44 in cash and up to an additional $1.50 in a
Contingent Value Right for each share of Chelsea stock they own.
The investigation concerns possible breaches of fiduciary duty and
other violations of state law by the Board of Directors of Chelsea
for not acting in the Company’s shareholders' best interests in
connection with the sale process. The transaction may undervalue
the Company given the strong demand for Chelsea’s recently
FDA-approved Parkinson’s disease treatment Northera, which treats
low blood pressure. In addition, an analyst has set a $12.00 per
share price target on Chelsea stock.
If you own shares of Chelsea common stock and wish to discuss
the legal ramifications of the proposed transaction, or have any
questions, you may e-mail or call the law office of Brodsky &
Smith, LLC who will, without obligation or cost to you, attempt to
answer your questions. You may contact Jason L. Brodsky, Esquire or
Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza,
Suite 602, Bala Cynwyd, PA 19004, by e-mail at
investorrelations@brodsky-smith.com, by visiting
http://brodsky-smith.com/756-chtp-chelsea-therapeutics-international-ltd.html,
or calling toll free 877-LEGAL-90.
Brodsky & Smith, LLC is a litigation law firm with extensive
expertise representing shareholders throughout the nation in
securities and case action lawsuits. The attorneys at Brodsky &
Smith have been appointed by numerous courts throughout the country
to serve as lead counsel in class actions and successfully
recovered millions of dollars for our clients and shareholders.
Attorney advertising. Prior results do not guarantee a similar
outcome.
Brodsky & Smith, LLCJason L. Brodsky, EsquireEvan J. Smith,
Esquire877-LEGAL-90investorrelations@brodsky-smith.comhttp://brodsky-smith.com/756-chtp-chelsea-therapeutics-international-ltd.html
Grafico Azioni Chelsea Therapeutics International, Ltd. (MM) (NASDAQ:CHTP)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Chelsea Therapeutics International, Ltd. (MM) (NASDAQ:CHTP)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a Chelsea Therapeutics International, Ltd. (MM) (NASDAQ): 0 articoli recenti
Più Chelsea Therapeutics International, Ltd. (MM) Articoli Notizie